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Abstract 
Endocrine-disrupting chemicals (EDCs) are exogenous substances that interfere with hormone synthesis, 
metabolism, or action. In addition, some of them could cause epi-genetic alterations of DNA that can be 
transmitted to the following generations. Because the developing organism is highly dependent on sex steroids 
and thyroid hormones for its maturation, the fetus and the child are very sensitive to any alteration of their 
hormonal environment. An additional concern about that early period of life comes from the shaping of the 
homeostatic mechanisms that takes place also at that time with involvement of epigenetic mechanisms along 
with the concept of fetal origin of health and disease. In this chapter, we will review the studies reporting effects 
of EDCs on human development. Using a translational approach, we will review animal studies that can shed 
light on some mechanisms of action of EDCs on the developing organism. We will focus on the major hormone-
dependent stages of development: fetal growth, sexual differentiation, puberty, brain development, and energy 
balance. We will also discuss the possible epigenetic effects of EDCs on human development. 
 
1. INTRODUCTION 
 Endocrine-disrupting chemicals (EDCs) are exogenous substances that interfere with hormone synthesis, 
metabolism, or action. Moreover, it appears that some of them could cause epigenetic alterations of the DNA that 
can be transmitted to the following generations. Animal and human studies have brought evidence that EDCs 
affect male and female reproduction, thyroid function, and control of energy balance. They could increase the 
risk of breast or prostate cancer as well as the risk of metabolic syndrome (Diamanti-Kandarakis et al., 2009). 
Because the developing organism is highly dependent on sex steroids and thyroid hormones for its maturation, 
the fetus and the child are very sensitive to any alteration of their hormonal environment. An additional concern 
about that early period of life comes from the shaping of the homeostatic mechanisms that takes place also at that 
time with involvement of epigenetic mechanisms along with the concept of fetal origin of health and disease 
(Gluckman, Hanson, & Low, 2011). Most studies have identified the perinatal period as a specific window of 
sensitivity. However, most of the reported effects were observed later in life. A review of the existing literature 
underlines the need for identification of early markers of exposure to EDCs. In this chapter, we will review the 
studies reporting effects of EDCs on human development. Using a translational approach, we will review animal 
studies that can shed light on some mechanisms of action of EDCs on the developing organism. We will focus 
on the major hormone-dependent stages of development: fetal growth, sexual differentiation, puberty, brain 
development, and energy balance. We will also discuss the possible epigenetic effects of EDCs on human 
development. 
 
2. CHALLENGES IN EVIDENCING ENDOCRINE DISRUPTION 
Before we discuss the different aspects of growth and maturation that are possibly altered by endocrine 
disruption, it is important to be aware of some challenges (Table 1.1) that we face in this area and that are 
relevant to all the specific aspects we will discuss later. Because the persistence of EDCs in the body and the 
environment is highly variable between few days such as for bisphenol A (BPA) (Rudel et al., 2011) and several 
decades such as for1,1-dichloro-2,2-bis (p-chlorophenyl) ethane (DDE) (Kirman, Aylward, Hays, Krishnan, & 
Nong, 2011), linking any disorder with previous EDC exposure is most difficult especially when latency is long 
between exposure and manifestation of health consequences. Also, the effects of EDCs can vary depending on 
the critical periods and duration of exposure. As will be discussed in the next sections, prenatal and early 
postnatal life is a period characterized by organization of the mechanisms that will drive homeostatic processes 
such as control of reproduction and energy balance. Obviously, EDC interference during those organizing 
periods could have much more severe consequences than later in life. Among the features of endocrine systems, 
they involve a cascade of activation or inhibition at different levels where EDCs play disturbing roles. We will 
see illustrations with puberty and reproduction that can be altered by effects at the hypothalamic-pituitary level 
as well as in target tissues (e.g., breasts). This also applies to energy balance through involvement of 
hypothalamic centers as well as fat tissue. Moreover, the physiological feedback systems through factors such as 
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sex steroids and leptin, respectively, will also be disturbed by EDCs. Further challenges come from observations 
that are inconsistent with classical toxicology: Low-dose mixtures that are consistent with human exposure can 
have effects not conforming to simple additive models (Christiansen et al., 2012; Kortenkamp, 2008); the dose—
response relationship can be nonmonotonic such as seen for BPA with U-shaped dose—response curves 
(Vandenberg et al., 2012). For both reasons, setting a threshold dose for EDC effects has become meaningless. A 
final issue is the highly variable latency between exposure and effects including multigenerational impact. 
 
Table 1.1  Challenges in the demonstration of endocrine disruption 
 
1 Variable persistence in the body and the environment 
2 Variable effects depending on the critical periods and duration of exposure 
3 Simultaneous action at different interrelated levels of endocrine systems 
4 Low-dose mixtures consistent with human exposure not conforming to 
simple additive models 
5 Nonmonotonic dose-response relationship 
6 Variable latency between exposure and effects including multigenerational 
impact 
 
3. ENDOCRINE-DISRUPTING CHEMICALS AND FETAL GROWTH 
Data concerning EDCs effects on fetal growth are scarce. However, one can hypothesize that fetal growth could 
be altered by endocrine disruption. Indeed, several EDCs cross the placental barrier and accumulate in the 
embryo or amniotic fluid (Diamanti-Kandarakis et al., 2009). The fetus is particularly sensitive to the effects of 
EDCs because of its dependency on hormones for development (Diamanti-Kandarakis et al., 2009). Moreover, 
animal studies have shown that most biotransformation enzymes are not produced until after birth (Pottenger et 
al., 2000), which means that fetuses might be exposed longer to higher concentration of EDCs. Clearance of 
BPA from fetal circulation, for instance, is slower than from maternal circulation (Takahashi & Oishi, 2000). It 
remains very complex to evaluate the effects of prenatal exposure to EDCs on fetal growth in human. Most 
studies focus on correlations between birth weight and serum or urinary levels of EDCs during pregnancy or at 
birth. Because of some limitations discussed later, few studies have identified a link between prenatal exposure 
to EDCs and fetal growth. We will review here some of the most significant human data as well as supporting 
animal studies. 
For BPA, for instance, few studies have been published and lead to various results. Miao et al. have shown that 
maternal exposure to BPA in the workplace was associated with decreased birth weight (Miao et al., 2011b) after 
adjusting for confounding factors. BPA exposure during pregnancy was evaluated through personal air-sampling 
measurements and exposure history. Chou et al. (2011) reported an increased risk of low birth weight in male 
newborn exposed prenatally to higher levels of BPA, while Padmanabhan did not report any effect of BPA 
neither on birth weight nor on length (Padmanabhan et al., 2008). In both studies, prenatal exposure to BPA was 
evaluated through a single measurement of BPA in maternal or cord blood. Philippat et al. have shown an 
association between urinary BPA concentration (in one urinary sample between 24 and 30 weeks of gestation) 
and birth weight following an inverse U shape (Philippat et al., 2012). However, serial urinary measurements 
before and during pregnancy have been shown to be highly variable and this variability was even increased 
during pregnancy (Braun et al., 2011a). Given this variability, it appears that more than one sample may be 
necessary to adequately classify gestational exposure to BPA especially because the half-life is short and the 
clearance rate is rather rapid as opposed to other EDCs. Rudel et al. (2011) showed that urinary excretion of 
BPA fell significantly 2-3 days after changing habits regarding food, drinks, and containers. In addition, for 
feasibility reasons, most studies focus on one or a few compounds and might miss exposure to other EDCs. 
Another limitation of current epidemiological studies is the studied parameters: most studies focus on birth 
weight, while they might oversee more subtle effects of EDCs on body composition. 
Some epidemiological studies have identified a negative correlation between exposure to polybrominated 
diphenyl ethers (PBDEs) and birth weight. PBDEs are flame-retardant chemicals used in the manufacture of 
infant products, furniture, and electronics. Ninety-seven percent of the American population appears to be 
contaminated by those persistent EDCs (Sjödin et al., 2008). Animal studies have shown that PBDEs disrupt 
thyroid function and alter behavior and memory (Herbstman et al., 2010). A prospective study in a population of 
286 pregnant women with low income living in California showed that higher concentrations of PBDEs in 
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maternal serum during pregnancy were associated with lower birth weight. Each 10-fold increase in 
concentrations of BDE-47, BDE-99, and BDE-100 was associated with a 115 g decrease in birth weight (Harley 
et al., 2011). Other smaller studies had similarly shown that higher concentrations of PBDEs were associated 
with a higher risk of delivering lower birth weight infants (Chao, Wang, Lee, Wang, & Päpke, 2007; Wu et al., 
2010). Some human studies, however, did not identify any effects of PBDE exposure on birth weight (Mazdai, 
Dodder, Abernathy, Hites, & Bigsby, 2003; Tan, Loganath, Chong, & Obbard, 2009). Animal models have not 
reported an effect of PBDEs on birth weight but identified a decreased weight gain of offspring during the 
postnatal period, which is comparable to the third trimester of pregnancy in human (Kodavanti et al., 2010). The 
tested doses were however elevated and difficult to translate into relevant environmental exposure. 
 
4. EDCs AND SEXUAL DIFFERENTIATION 
Sexual differentiation depends on prenatal hormonal environment. 
Therefore, exposure to EDCs may be associated with disorders of development of the reproductive system by 
altering this hormonal environment. Cryptorchidism and hypospadias in the male newborn and low sperm counts 
and increased risk of testicular germ cell cancer in young adult males belong to a lifelong spectrum of disorders 
caused by early impairment of testicular function. This association of disorders has been proposed as the 
testicular dysgenesis syndrome (TDS) (Skakkebaek, Rajpert-De Meyts, & Main, 2001). TDS appears to involve 
deficient testosterone (androgen) production by the fetal testis (Sharpe & Shakkebaek, 2008). Indeed, it has been 
shown that normal development of the male reproductive system depends on the crucial role of androgen within 
an early fetal time window, called the mas-culinization programming window (Welsh et al., 2008), which 
influences the reproductive capacity throughout life. Thus, EDCs, which interfere with the synthesis or action of 
androgens, can have deleterious consequences for the developing male genital tract and appear to be risk factors 
for TDS (Bay, Asklund, Skakkebaek, & Andersson, 2006). 
Several animal experimental studies have confirmed this hypothesis, especially using the phthalates, a group of 
anti-androgenic compound present in personal care products, coating of pharmaceutical products, and soft 
plastics. Male offspring of pregnant rats exposed to 250 mg/kg or more of monobenzyl phthalate, a major 
metabolite of butyl benzyl phthalate, on days 15-17 of pregnancy had an increased incidence of undescended 
testes and a decreased anogenital distance, a marker of androgenic impregnation (Ema, Miyawaki, Hirose, & 
Kamata, 2003). Likewise, Fisher et al. reported a TDS-like condition after fetal rat exposure to phthalate esters 
(Fisher, Macpherson, Marchetti, & Sharpe, 2003). The effects of phthalates on male sexual development in rats 
result from alterations of Leydig cell function leading to androgen insufficiency, which can be responsible of 
hypospadias or cryptorchidism. Swan et al., in 2005, have demonstrated a similarly reduced androgenization 
after phthalate exposure in humans since boys whose mother had elevated prenatal phthalate exposure, measured 
through phthalate urinary concentration, had shorter anogenital distance and impaired testicular descent (Swan et 
al., 2005). Main et al. (2006) reported that free testosterone levels at age 1-3 months were negatively correlated 
with monoethyl phthalate (MEP) levels in breast milk collected during that period. A reduced Leydig cell 
response to LH was suggested by the increasing LH/free testosterone ratio in relation to milk MEP levels (Main 
et al., 2006). Though these findings suggest similar mechanisms in both rodents and humans, recent studies 
indicate possible differences in testicular sensitivity to phthalate effects among humans and rodents. Given the 
difficulty to evaluate the production of testosterone by the human fetal testis, Mitchell et al. (2012) and Heger et 
al. (2012) used a xenograft model to evaluate the effects of phthalates on steroidogenesis of human fetal testis. 
They used second-trimester human fetal testes xenografts, which were exposed to phthalates for 1-4 days or 21 
days. There was no difference in serum testosterone levels or in the seminal vesicles weight between xenograft 
model exposed to DBP or MBP and controls (Mitchell et al., 2012). Heger et al. (2012) reported that 
steroidogenesis was suppressed in rodent xenograft but not in human xenografts in such conditions. Germ cell 
alterations however were observed in human xenografts. 
Data concerning BPA are controversial. In animal studies, perinatal BPA exposure has been shown to lead to 
decreased levels of testicular testosterone (Richter et al., 2007) or impaired fertility (Salian, Doshi, & Vanage, 
2009). These data are consistent with two human epidemiological studies highlighting the negative effect of 
BPA on the male reproductive function, by modifying sex hormone concentrations (Galloway et al., 2010; 
Meeker, Calafat, & Hauser, 2010). However, other animal and human studies have reported conflicting results 
when studying effect of BPA on male reproductive tract. Indeed, in human, an association between maternal 
exposure to BPA during pregnancy and a shorter anogenital distance in male offspring has been shown 
(LaRocca, Boyajian, Brown, Smith, & Hixon, 2011), while cord blood BPA levels are not different between 
normal and cryptorchid boys (Ema et al., 2001). In rodents, several studies have reported that BPA exposure in 
utero had no effect on the adult male reproductive system (Fénichel et al., 2012; Kobayashi, Ohtani, Kubota, & 
Miyagawa, 2010; Meeker et al., 2010; Miao et al., 2011a). 
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Interestingly, one recent study has evaluated the effects of perinatal exposure to BPA and diethylhexyl phthalate 
on gonadal development of male mice. Using a mixture of EDCs (DEHP and BPA) better illustrates the 
synergistic effects of a combination of EDCs as encountered in the environment (Xi et al., 2012). Significant 
reduction in testicular weight and/or epididy-mal sperm count was identified in immature and mature animals on 
postnatal days 15 and 42. Serum testosterone levels were also decreased. These authors however used doses of 
EDCs that were higher than those relevant for human exposure and mixture effects. 
We discussed earlier the peripheral effects of EDCs on sexual differentiation. However, brain sexual 
differentiation should not been ignored because of its sensitivity to hormonal environment and its significance 
for reproduction. It is well established that testosterone secreted by the fetal and neonatal testis is involved in 
brain sexual differentiation, most likely after it has been converted to estradiol by aromatase in specific brain 
regions during critical periods of development (Rubin et al., 2006). Thus, perinatal exposure to BPA could alter 
sex steroid action in the rodent brain and disrupt the development of sexually dimorphic pathways. This concept 
is confirmed by data available in animals. Kubo et al. demonstrated that BPA exposure during prenatal and 
postnatal period abolished the sex differences in open-field behavior in mice. Likewise, it increases the size of 
the locus coeruleus (LC) in males and decreases LC volume in females (Kubo et al., 2003). Rubin et al. also 
identified an effect of BPA on brain sexual differentiation since exposure to low doses of BPA decreased the 
sexually dimorphic population of tyrosine hydroxylase (TH) neurons in the rostral periventricular preoptic area, 
an important brain region for estrous cyclicity and estrogen-positive feedback (Rubin et al., 2006). Similarly, a 
decreased sexual dimorphism in the number of corticotropin-releasing hormone neurons in the bed nucleus of the 
stria terminalis has been shown after BPA exposure, whereas there was no effect in the preoptic area (Funabashi, 
Kawaguchi, Furuta, Fukushima, & Kimura, 2004). Moreover, Tando et al. have shown that BPA exposure can 
affect brain development in a sex-specific manner. Indeed, a significant reduction in the total volume and density 
of dopaminergic neurons in the substantia nigra (SN) is observed only in adult female offspring after maternal 
BPA treatment during pregnancy and lactation (Tando et al., 2007). The cited studies underline the need to focus 
on both sexes when studying EDCs in order to identify sexual dimorphism in sensitivity to endocrine disruption. 
 
5. EDCs AND PUBERTY 
The effects of EDCs on puberty have been investigated mainly through variations in pubertal timing with 
emphasis on the onset of sexual maturation. Therefore, our current knowledge may miss some additional effects 
such as changes in age at occurrence of regular (ovulatory) cycles. As stated earlier, the appraisal of EDC effects 
on puberty is complex due to involvement of possible effects on peripheral target organs such as uterus and 
breast in females and penis in males as well as effects on neuroendocrine control of maturation through 
hypothalamic-pituitary maturation. Second, pubertal timing can be influenced by exposure close to the time of 
puberty or during the process of puberty as well as much earlier in life since pubertal timing is one among the 
parameters programmed during fetal/neonatal life. The published human observations after exposure that was 
estimated to have occurred pre- or neonatally are summarized in Table 1.2 and those after postnatal exposure in 
Table 1.3. The data are scarce and it appears that no firm conclusion can be drawn. It is of note that, except in 
conditions of accidental massive exposure to a single class of EDCs, mixtures are likely involved in most 
conditions. Therefore, measurement of particular compounds and study of a compound in relation to pubertal 
timing may involve some biases. 
 
6. EDCs AND BRAIN DEVELOPMENT 
Several studies have reported that prenatal or early postnatal exposure to some EDCs is associated with 
alterations of cognitive or motor functions in children. Knowing the fundamental role played by thyroid 
hormones and sex steroids in cortex development, one can hypothesize that disruption of those hormones could 
cause alteration of the development of the cerebral cortex and of its functions later in life. We will review here 
the human data suggesting a causal effect for endocrine disrupters on impairment of cortical functions and 
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Table 1.2 Effect of prenatal or early postnatal exposure to EDCs on timing of breast development and menarche 
 
Pubertal 
    
timing Early  Normal Delayed 











PCBs   Vasiliu et al. (2004), 
Yang et al. 
(2005) 
 
Dioxins   Leijs et al. (2008), 
Warner et al. 
(2004) 





Veje et al. 
(2012) 
   
 
 
Table 1.3 Effect of postnatal exposure to EDCs on timing of breast development and menarche 
Pubertal      
timing Early  Normal  Delayed 
Event Breast Menarche Breast Menarche Breast                          
Menarche 
DDE(+DDT)  Ouyang et al. 
(2005) 
Wolff et al. (2008) Denham et al. 
(2005) 
 
PCBs Denham et al. 
(2005) 
Denham 
et al. (2005) 
Den Hond et al. (2002), 
Wolff et al. (2008) 
Den Hond 
et al. (2002) 
 
Dioxins    Den Hond 
et al. (2002) 
Den Hond et al. 
(2002) 
Phthalates Colon et al. 
(2000), Wolff et 
al. (2010) 
 Lomenick et al. (2010), 
Frederiksen et al. (2012) 




  Strom et al. (2001) Strom et al. 
(2001) 
Wolff et al. (2008, 2010) 
 
6.1. Disruption of thyroid function and brain development 
Thyroid hormones are known to be essential for brain development. They regulate progenitor proliferation and 
differentiation, neuron migration, and dendrite outgrowth (Parent, Naveau, Gerard, Bourguignon, & Westbrook, 
2011). Even mild thyroid hormone insufficiency in humans can produce measurable deficits in cognitive 
functions (Zoeller & Rovet, 2004). Thyroid hormone action is mediated by two classes of nuclear receptors 
(Forrest & Vennström, 2000) that exhibit differential spatial and temporal expressions in the brain, suggesting 
that thyroid hormones have variable functions during brain development (Horn & Heuer, 2010). This differential 
expression of thyroid hormone receptors explains the critical period of thyroid hormone action on brain 
development as suggested by models of maternal hypothyroidism or congenital hypothyroidism (Zoeller & 
Rovet, 2004). Depending on the timing of onset of hypothyroidism, the offspring will display problems of visual 
attention, gross or fine motor skills, or language and memory skills. Similarly, one can hypothesize that 
disruption of thyroid function by EDCs will have different effects based on the timing of exposure. However, 
few studies focused on that aspect. 
Polychlorinated biphenyls (PCBs) form a group of widespread environmental contaminants composed of 209 
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different congeners used in a wide variety of applications. Their production was banned in the 1970s but PCBs 
are still present in the environment due to their high stability. PCBs were among the first EDCs identified as 
responsible for alterations of cognitive functions. Indeed, impaired memory and altered learning abilities have 
been associated with prenatal exposure to EDCs in humans and rodents (Schantz, Widholm, & Rice, 2003). In 
animal models, perinatal exposure to PCBs has been consistently associated with a decrease of thyroid hormone 
concentration in maternal serum as well as pup serum (Brouwer et al., 1998). Some but not all epidemiological 
studies in human have found an association between PCB body burden and thyroid hormone levels (Langer, 
2008). This disruption of thyroid function could explain some of the effects of PCBs on the developing brain. 
Indeed, animal models have shown that the ototoxic effects of PCBs could be partially ameliorated by thyroxin 
replacement and PCBs seem to alter some of the developmental processes in the cortex and the cerebellum that 
are dependent on thyroid hormones (Diamanti-Kandarakis et al., 2009). However, recent publications raise 
important issues. First, PCBs produce paradoxical effects on the thyroid system; PCBs reduce serum T4 but 
increase the expression of some genes regulated by TH (Zoeller, Dowling, & Vas, 2000). Second, while some 
report agonistic actions of PCBs on the TH receptor (Gauger et al., 2007), others report antagonistic actions 
(Koibuchi & Iwasaki, 2006). Although this appears paradoxical, it is consistent with in vivo studies showing that 
PCBs can exert different actions on TH response genes in the developing brain (Bansal & Zoeller, 2008). In 
addition, as suggested by in vitro models, some congeners can have direct toxic effects on neurons through 
alterations of neurotransmission or intracellular signaling, independent of disruption of thyroid hormones. 
PBDEs are semivolatile and migrate into house dust, placing the young children at risk of higher exposure 
(Stapleton et al., 2008). Animal studies suggest that pre- and postnatal exposure to different PBDE congeners 
causes long-lasting behavioral alterations, in particular alterations of motor activity and cognitive behavior 
(reviewed in Costa & Giordano, 2007). As it is the case for other EDCs, some windows of susceptibility have 
been identified during pre- and postnatal brain development (Eriksson, Viberg, Jakobsson, Orn, & Fredriksson, 
2002; Kuriyama & Chahoud, 2004). Recent studies have shown that exposure to PBDEs causes alteration of 
thyroid hormone levels in pregnant women (Chevrier et al., 2010) and infants (Herbstman et al., 2008) as it is the 
case in rodents. Only very few studies, however, have focused on the molecular or cellular effects of perinatal 
exposure to PBDEs in vivo. Viberg et al. have reported a decrease of cholinergic nicotinic receptors in the 
hippocampus after exposure to BDE-99 and BDE-153 (Viberg, Fredriksson, & Eriksson, 2003). However, the 
link between such a decrease and the behavioral effects of PBDEs is still unclear. Other teams have reported that 
exposure to PBDEs reduced hippocampal long-term potentiation and decreased brain-derived neurotrophic factor 
expression in the brain (Viberg, Mundy, & Eriksson, 2008). While several studies have reported negative effect 
of PBDEs on brain development and cognitive function in animals, there is relatively little information about 
adverse health effects of PBDEs in humans. Some very recent studies have identified a correlation between 
prenatal exposure to PBDEs and alteration of cognitive functions. Eskenazi et al. have reported that both prenatal 
and early postnatal PBDE exposures were associated with poorer attention and fine motor coordination and 
cognition in a cohort of 300 school-age children at 5 and 7 years of age (Eskenazi et al., 2012). 
 
6.2. Disruption of sex steroid action and brain development 
Sex steroids also play a major role during brain development. Androgens and estrogens sculpt the gender-
specific differences of brain regions involved in behavior, learning, memory, mood, and socialization. Both 
androgens and estrogens stimulate progenitor proliferation in the cortex and hippocampus. However, it has been 
shown in the hippocampus that androgens preferably support neurogenesis, whereas estrogens promote 
gliogenesis (Zhang, Konkle, Zup, & McCarthy, 2008). Estrogens and aromatizable androgens also regulate 
dendritic outgrowth, synaptic function, and neuronal connectivity. Because several EDCs affect estrogen and 
androgen receptors directly or indirectly through an effect on sex steroid biosynthesis, it is important to examine 
the effects of those EDCs on development of the cerebral cortex, the hippocampus, and the hypothalamus. As an 
illustration, we will summarize here some of the effects of BPA on behavior and cognitive functions in animals 
and humans. As developed earlier in this chapter, BPA has been shown to alter sexually dimorphic behaviors 
such as aggression, anxiety, and exploration in rodents (Palanza, Gioiosa, vom Saal, & Parmigiani, 2008; vom 
Saal et al., 2007). Sexually dimorphic disorders such as autism, attention deficit, or hyperactivity could be 
correlates of these animal behaviors and might be related to early exposure to EDCs. Braun et al. (2011a) studied 
a prospective cohort of 244 mothers and their 3-year-old children. BPA exposure was evaluated by measuring 
BPA levels in maternal urine at 16 and 26 weeks of gestation as well as BPA urinary levels in the children at 1, 
2, and 3 years of age. Each 10-fold increase in gestational BPA exposure was associated with more anxious and 
depressed behavior and poorer emotional control in the 3-year-old children (Braun et al., 2011b). Effects 
appeared to be sexually different since girls, for example, exhibited increased hyperactivity, while boys exhibited 
decreased hyperactivity after gestational exposure to BPA. It is not known however if those effects will persist 
later in life. Those results illustrate the importance of the window of exposure since behavior appeared to be 
affected by prenatal exposure to BPA but not by postnatal exposure. 
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One can hypothesize that perinatal exposure to EDCs could lead to alterations of the development of brain 
circuits and an increased risk of neu-rodevelopmental deficits. Indeed, the developing brain is remarkably 
malleable. Such plasticity is advantageous in that it allows the refinement of the basic organization in response to 
the surrounding environment. However, this plasticity also can be maladaptive in that these critical 
developmental periods are extremely vulnerable to disruption as illustrated by neurodevelopmental disorders 
such as autism or fetal alcohol syndrome. Such diseases often are characterized by a disruption of functional 
brain circuits in the setting of grossly normal brain morphology. Animal models could be used to identify 
cellular or molecular markers of EDCs effects. Indeed, the synapse is the fundamental unit responsible for 
formation of brain circuitry and thus should serve as a sensitive indicator of disruption by EDCs. Leranth et al. 
have shown that adult exposure to BPA prevents the synaptogenic response to estradiol in hippocampus and 
prefrontal cortex in ovariectomized nonhuman primates (Leranth et al., 2008a) and antagonizes spine formation 
induced by estrogens and testosterone in limbic areas in gonadectomized female and male rats (Leranth et al., 
2008b; MacLusky et al., 2005). Those data were obtained after BPA exposure during adult life. A more recent 
study, however, showed that gestational exposure to BPA reduced the number of dopamine neurons in the 
midbrain and the number of spine synapses in the hippocampus, while no effects were observed when the 
animals were exposed during the juvenile period (Elsworth et al., 2013). 
 
7. EDC AND ENERGY BALANCE 
The concept of developmental or fetal origin of adult disease was developed by Barker at the end of the 1980s. 
He showed that nutritional status during early life is linked to an increased risk of cardiovascular disease in 
early-adult life and premature death as a consequence (Barker & Osmond, 1986; Barker, 2004). Several studies 
initially focused on the correlation between fetal growth (often assessed by the birth weight) and the 
predisposition to adult disease, in particular metabolic disorders. Thereby, it has been shown that low birth 
weight is correlated with a major risk to develop insulin resistance (Hales et al., 1991), metabolic syndrome 
(Barker et al., 1993), and obesity (Ravelli, Van Der Meulen, Osmond, Barker, & Bleker, 1999) during adulthood. 
The possible implication of EDCs during pregnancy in the development of diseases in adulthood was first 
evocated in the early 1970s, after millions of pregnant women were prescribed DES (diethylstilbestrol). Indeed, 
daughters of woman treated by DES, a pharmaceutical estrogen given to prevent miscarriages, had an increased 
incidence of vaginal adenocarcinoma and benign reproductive lesions (Herbst, Ulfelder, & Poskanzer, 1971). 
All these data highlight intrauterine and early postnatal life as critical periods for future health. According to this 
idea, one can hypothesize that the significant increase of obesity and metabolic syndrome incidence might be 
linked to perinatal disrupting factors acting as predisposition factors. Exposure to EDCs perinatally, by altering 
hormonal environment, could be associated with disorders of energy balance throughout subsequent life. 
This hypothesis has been evocated in several animal studies. Significant data have been obtained for DES and 
BPA. Howdeshell et al. showed that pregnant mice fed with BPA (2.4 µg/kg/day on 11-17 days of gestation) had 
heavier pups than control mice (Howdeshell, Hotchkiss, Thayer, Vandenbergh, & vom Saal, 1999). This finding 
was confirmed in 2001, by Rubin, who exposed pregnant rat to BPA (0.1 mg BPA/kg/day or 1.2 mg 
BPA/kg/day) and observed an increase in body weight of the male and female offspring, an increase that was 
more persistent in females than males (Rubin et al., 2001). BPA has also been shown to reduce glucose tolerance 
and increase insulin resistance in male offspring at 6 months of age (Alonso-Magdalena et al., 2010). 
Interestingly, some studies suggest that these changes in glucose regulation are persistent in adult offspring and 
are worsened if the offspring is fed with a high-fat diet (Wei et al., 2011). The data of Ryan et al., however, are 
not consistent with this findings since they have shown that BPA exposure during pregnancy (0.25 µg/kg/day) 
results in accelerated growth early in life but does not result in impaired glucose regulation in adulthood, even 
when the mice are maintained on a high-fat diet (Ryan et al., 2010). 
In addition to altering glucose tolerance, BPA appears to affect adipogenesis very early in life. Female pups born 
from dams exposed to 1 mg/L of BPA in drinking water during gestation and lactation showed adipocyte 
hypertrophy and overexpression of lipogenic genes such PPAR-γ, SREBP-IC, SCD-1, and C/EBP-ALPHA 
(Somm et al., 2009). Masuno et al., using 3T3-L1 cells, a preadipocyte cell line that differentiates into mature 
adipocytes, have shown that BPA leads to an accelerated differentiation into adipocytes, causing high 
accumulation of triglycerides and lipoprotein lipase (Masuno, Iwanami, Kidani, Sakayama, & Honda, 2005; 
Wang, Sun, Hou, Pan, & Li, 2012). More recently, the effect of BPA on adipogenesis has been confirmed by 
Sargis et al., who assessed the ability of BPA (100 nM) to activate the glucocorticoid receptor and thereby 
increase lipid accumulation and expression of adipocytic proteins in mature adipocytes (Sargis, Johnson, 
Choudhuryl, & Bradyl, 2010). 
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In addition, exposure to BPA, at 10 nM, 1 µM, and 80 µM, increased the mRNA expression and enzymatic 
activity of 11β-HSD1, an enzyme that converts the inactive hormone cortisone to the active hormone Cortisol in 
adipose tissues and promotes adipogenesis (Masuno et al., 2002). Interestingly, BPA at low doses (1 and 10 nM) 
also decreases adiponectin production from human adipose tissue (Hugo et al., 2008). Adiponectin is an 
adipocyte-specific hormone that increases insulin sensitivity and reduces tissue inflammation (Whitehead, 
Richards, Hickman, Macdonald, & Prins, 2006). Similarly, it has been shown that release of IL-6 and TNF 
alpha, two inflammatory cytokines involved to obesity, is stimulated by BPA exposure (Ben-Jonathan, Hugo, & 
Brandebourg, 2009). 
Effects of BPA on energy balance are also suggested by studies in humans. A large cross-sectional study in 
human, by Lang et al., has shown that higher urinary BPA concentrations in adults were associated with 
diagnosis of cardiovascular disease and diabetes and abnormal concentrations of three liver enzymes (gamma-
glutamyltransferase (GGT), alkaline phosphatase, and lactate dehydrogenase) (Lang et al., 2008; Vom Saal & 
Myers, 2008). However, measurements of BPA were made in adults and do not bring any information about the 
critical perinatal period identified in animals. A recent study in children showed that incidence of obesity was 
increased among children who had higher urinary BPA concentrations (Trasande, Attina, & Blustein, 2012). 
However, it is difficult to correlate BPA exposure and BPA urinary excretion. Moreover, the causal link remains 
difficult to establish. Indeed, obese children could, for instance, consume more BPA-contaminated food such as 
canned sodas, which would explain their higher urinary BPA levels. Further longitudinal studies are thus 
necessary in humans in order to determine if gestational and postnatal exposure to BPA could lead to an 
increased risk of metabolic syndrome later in life. 
 
8. EPIGENETIC PERSPECTIVE ON THE DEVELOPMENTAL EFFECTS OF EDCs 
Epigenetics refers to heritable alterations that are not due to changes in DNA sequence. Rather, epigenetic 
modifications, such as DNA methyla-tion and histone modification, alter DNA accessibility and chromatin 
structure, thereby regulating patterns of gene expression. This mechanism appears as an adaptive response to 
insults during the developmental period, such as variations in maternal diet or sex steroids (Fowden & Forhead, 
2009; Lillycrop et al., 2007). For example, it has been recently proposed that maternal undernutrition could 
cause epigenetic changes in the proopiomelanocortin (POMC) and glucocorticoid receptor genes in the fetal 
hypothalamus (Stevens, Begum, & White, 2011). POMC-derived peptides synthesized in neurons of the 
hypothalamus play a central role in the control of energy homeostasis (Coll, Sadaf, Chains, Yeo, & O'Rahylly, 
2004). 
EDCs, by interfering with the nutritional and/or hormonal environment during fetal life, may interfere with 
epigenetic programming, which can be passed from one cell generation to another and persist in adulthood 
(MClachlan, 2001; Anway, Cupp, Uzumcu, & Skinner, 2005). Moreover, epigenetic modifications, when they 
occur in the gonads, can be transmitted to the next generations as illustrated by Anway et al. (2005). 
Some studies have reported the effects of prenatal BPA exposure on epigenetic mechanisms. Dolinoy et al., 
using the Agouti viable yellow mouse model, have shown that BPA exposure during pregnancy led to DNA hyp-
omethylation of the offspring epigenome. Interestingly, this effect can be counteracted by maternal dietary 
supplementation (diet enriched with methyl group donors) (Dolinoy, Huang, & Jirtle, 2007). It will be necessary 
to examine the correlation between BPA-induced epigenetic alterations, modification in gene expression, and 
phenotype expression. But the absence of hypomethylation when supplementing maternal dietary during 
pregnancy suggests possible means for reducing risk of disease. Other studies supported epigenetic effects of 
BPA. Bromer et al. have shown that in utero exposure to high doses of BPA increased the expression of the 
homeobox gene Hoxa 10 in the uterus of female offspring at 2 weeks of age. This was correlated with significant 
demethylation of specific CpG sites in the Hoxa 10 gene, a gene necessary for uterus development. It is 
interesting to note that Hoxa 10 DNA methylation was not altered in adult mice treated with these doses of BPA. 
It highlights the great vulnerability of the fetus and the existence of a critical developmental window for the 
epigenetic effects of EDCs (Bromer, Zhou, Taylor, Doherty, & Taylor, 2010). Other studies have shown an 
association between in utero exposure to BPA and hypomethylation of specific sites in genes involved in cancer 
development (Ho, Tang, Belmonte de Frausto, & Prins, 2006). 
 
9. CONCLUSION 
The fetus and child are particularly exposed to EDCs. Indeed, several of those EDCs cross the placental barrier 
or accumulate in maternal milk. Moreover, childhood behavior such as crawling or placing objects in their 
mouth increases exposure. Because of its high dependence on sex steroids and thyroid hormones for its 
maturation, the developing organism is very sensitive to any alteration of its hormonal environment. 
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Epidemiological studies have reported effects of EDCs on major hormone-dependent stages of development: 
fetal growth, sexual differentiation, puberty, brain development, and energy balance. However, the 
epidemiological data concerning the EDCs effects on the developing fetus and child are relatively scarce. 
Besides the challenges listed in Table 1.1, epidemiological studies present several other difficulties. Accurate 
quantification of exposure throughout pregnancy and childhood is difficult as described for BPA. In addition, for 
practical reasons, most epidemiological studies have to focus on one group of compounds and ignore other EDCs 
or risk factors. Genetic susceptibility to endocrine disruption or the effect of associated stresses of other nature is 
still to be studied. 
An analysis of the literature underlines the need for identifying early and fine markers of EDC effects. Animal 
models can help to unravel the mechanisms of action of EDCs and discover new markers that could underlie 
alterations of function. 
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